Drug Information Association Logo

Customized Onsite Training

Preserve Your Travel Budget and Maximize Your Time

DIA is recognized throughout the life sciences community as the definitive source for knowledge and content. That’s why top companies around the world trust DIA to deliver current, relevant, and effective education and professional Customized Onsite Training.

Join some of the most successful companies who chose DIA Customized Onsite Training to support their training goals and objectives:

• Abbott Laboratories  • Merck
• Actelion  • Millennium: Takeda Oncology Co.
• AMAG Pharmaceuticals  • Novartis 
• Amgen  • Novo Nordisk
• Auxilium Pharmaceuticals, Inc.  • Organogenesis Inc.
• Eli Lilly and Company  • Sepracor
• Fresenius Biotech  • Shire Human Genetic Therapies 
• Genentech  • Takeda Pharmaceuticals
• Janssen Alzheimer Immunotherapy R&D  • UNC Chapel Hill
• Lernia Training Solutions  • Vertex Pharmaceuticals
• Medtronic, Inc.   

We know you and your team are busy professionals with full schedules and limited budgets. DIA can tailor a training course or curriculum specifically for your team, department, or entire company.  You will receive quality content and expert delivery - right in your workplace, created for you and your company, all while earning continuing education credits. Contact DIA now to bring our outstanding training program to your company!

Please select from the rows below to display course details.

Customized Onsite Training 

Adaptive Design in Clinical Trials: When and How to Apply 3474872
Advanced GCP Study Monitoring 24056
Advanced Signal Detection - Tools, Triage, Evaluation, and Escalation 3443006
Advanced Workshop on QPPV Tool Box - Your Key to Success 6258303
Art of Writing a Clinical Overview 24458
Basics of the IND Phase 10307
Basics of the NDA Phase 10306
Benefit-Risk Management 29255
Biosimilar Development: Strategies and Regulatory Requirements for Global Market Entry 2686219
Building the eCTD: Practical Solutions to Compile Electronic Submissions 14773
Clinical Project Management 13242
Clinical Statistics for Nonstatisticians 10381
Developing Standard Operating Procedures 10380
Development of a Clinical Study Report 10379
Diagnosis and Management of Drug-Induced Liver Injury (DILI): Clinical Trials and Post-Marketing 2162769
Drug Safety and Pharmacovigilance Across the Product Lifecycle 29675
Electronic Submissions: The Next Era of Electronic Submissions 2526234
Enterprise Resource Management 16489
Essentials and Overview of the Regulatory Framework in Europe 10377
Essentials of Project Management 10308
EU Health Authorities Scientific and Regulatory Advice 6475737
EU Regulation of In-Vitro Diagnostics 3170749
EU-RMP Creation 6444309
European Regulatory Affairs: Keeping Your Finger on the Pulse of Marketing Authorizations 4005534
Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing 14767
Executing and Controlling Biopharmaceutical Projects 11335
Fundamentals of Clinical Research Monitoring 10376
Fundamentals of Project Management for the Nonproject Manager 10309
Global CTD Dossier – Regulatory aspects and focus on quality documentation including concepts of Quality by Design 20794
Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America and Other Emerging Markets 30108
Good Clinical Practices for the Clinical Research Professional 10375
High Performance Biopharm Teams 14215
How to Manage a Successful Health Authority Interaction? 2088953
How to Prepare for a Safety Inspection 20691
How to Prepare for Pharmacovigilance Audits and Inspections in Europe 21617
HTA for Non-HTA User 27760
Innovative Statistical Approaches for Clinical Trials 10386
Introduction to Computer Systems Validation 19537
Introduction to Portfolio Management and Performance Metrics 16188
Introduction to Signal Detection and Data Mining 20694
Medical Affairs Training 5695546
Medical Approach in Diagnosis and Management of ADRs 11120
Medical Devices: Regulation and lifecycle management 23033
Medical Writing of Periodic Safety Update Reports (PSUR/PBRER) 6444317
Navigating Chemistry, Manufacturing and Controls through the Drug Development Process 19367
New Drug Product Development and Life Cycle Management 13461
Oversight of Clinical Monitoring: Trends and Strategies 13871
Overview of Drug Development 10310
Overview of Drug Development in Japan 12679
Paediatric Investigation Plans (PIP) 29280
Post-Authorisation Studies 3321889
Postmarketing Drug Safety and Pharmacovigilance 21684
Practical Guide for Pharmacovigilance: Clinical Trials and Post Marketing 17166
Pre-Marketing Clinical Safety 2164753
Premarketing Clinical Safety and Pharmacovigilance 21656
Preparing for a US FDA Advisory Committee Meeting 28296
Project Information, Communication, and Knowledge Management 16153
Project Risk Management 16145
Proven Strategies for Creating an Effective Clinical Research Program 28775
Quality by Design - Quality by Design - New concepts for Chemical and Biotech Product Development and Optimisation 23689
Regulatory Affairs for Biologics 21649
Regulatory Affairs for Combination Products 7121981
Regulatory Affairs: The IND, NDA, and Postmarketing 10305
Risk Management and Safety Communication Strategies 22320
Signal Management in Pharmacovigilance 21608
Strategies for Good Clinical Practice Audits 10374
The Basics of Clinical Data Management From Start to End 10382
The Development of Biopharmaceuticals - The Big Picture, Innovation and Scientific Requirements 26005
Training Course for eCTD Submissions in Switzerland 23714